PHVS
Price
$25.70
Change
-$0.30 (-1.15%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
1.69B
90 days until earnings call
Intraday BUY SELL Signals
XNCR
Price
$14.44
Change
+$0.50 (+3.59%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
995.46M
49 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PHVS vs XNCR

Header iconPHVS vs XNCR Comparison
Open Charts PHVS vs XNCRBanner chart's image
Pharvaris
Price$25.70
Change-$0.30 (-1.15%)
Volume$5.88K
Capitalization1.69B
Xencor
Price$14.44
Change+$0.50 (+3.59%)
Volume$17.76K
Capitalization995.46M
PHVS vs XNCR Comparison Chart in %
View a ticker or compare two or three
VS
PHVS vs. XNCR commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHVS is a Hold and XNCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (PHVS: $26.00 vs. XNCR: $13.94)
Brand notoriety: PHVS and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PHVS: 48% vs. XNCR: 65%
Market capitalization -- PHVS: $1.69B vs. XNCR: $995.46M
PHVS [@Biotechnology] is valued at $1.69B. XNCR’s [@Biotechnology] market capitalization is $995.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $115.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PHVS’s FA Score shows that 1 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • PHVS’s FA Score: 1 green, 4 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, PHVS is a better buy in the long-term than XNCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PHVS’s TA Score shows that 5 TA indicator(s) are bullish while XNCR’s TA Score has 3 bullish TA indicator(s).

  • PHVS’s TA Score: 5 bullish, 3 bearish.
  • XNCR’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, PHVS is a better buy in the short-term than XNCR.

Price Growth

PHVS (@Biotechnology) experienced а +8.11% price change this week, while XNCR (@Biotechnology) price change was -0.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.47%. For the same industry, the average monthly price growth was +3.45%, and the average quarterly price growth was +44.85%.

Reported Earning Dates

PHVS is expected to report earnings on Apr 14, 2026.

XNCR is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (+0.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHVS($1.69B) has a higher market cap than XNCR($995M). PHVS YTD gains are higher at: -6.306 vs. XNCR (-8.948). XNCR has higher annual earnings (EBITDA): -85.79M vs. PHVS (-166.91M). XNCR has more cash in the bank: 471M vs. PHVS (329M). PHVS has less debt than XNCR: PHVS (579K) vs XNCR (69.3M). XNCR has higher revenues than PHVS: XNCR (150M) vs PHVS (0).
PHVSXNCRPHVS / XNCR
Capitalization1.69B995M170%
EBITDA-166.91M-85.79M195%
Gain YTD-6.306-8.94870%
P/E RatioN/AN/A-
Revenue0150M-
Total Cash329M471M70%
Total Debt579K69.3M1%
FUNDAMENTALS RATINGS
XNCR: Fundamental Ratings
XNCR
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
5
SEASONALITY SCORE
1..100
44

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PHVSXNCR
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
67%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
84%
Bearish Trend 6 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
68%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
PHVS
Daily Signal:
Gain/Loss:
XNCR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TARKX37.100.27
+0.73%
Tarkio
NLSIX20.15-0.03
-0.15%
Neuberger Berman Long Short Instl
IBARX26.19-0.08
-0.30%
Nomura Balanced Fund Class R6
SGMIX10.10-0.04
-0.39%
SEI Global Managed Volatility I (SIMT)
CVLEX16.03-0.07
-0.43%
Cullen Value Retail

PHVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHVS has been loosely correlated with MGTX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if PHVS jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHVS
1D Price
Change %
PHVS100%
-0.38%
MGTX - PHVS
37%
Loosely correlated
+1.93%
NUVL - PHVS
35%
Loosely correlated
+2.03%
INKT - PHVS
35%
Loosely correlated
-1.67%
BEAM - PHVS
34%
Loosely correlated
+2.55%
DSGN - PHVS
33%
Loosely correlated
+4.93%
More

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with NUVL. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
-1.62%
NUVL - XNCR
61%
Loosely correlated
+2.03%
KURA - XNCR
59%
Loosely correlated
+0.44%
CRNX - XNCR
59%
Loosely correlated
-1.88%
IDYA - XNCR
58%
Loosely correlated
-4.75%
SYRE - XNCR
57%
Loosely correlated
-3.87%
More